Search

everythinglearnresearchcommunity

for

Search:↓

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

The patient with lupus and Degos' disease showed significant improvement with treatment.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

A rare form of lupus can cause severe nerve damage and other symptoms, but treatment can help.

Blocking certain immune signals can reduce skin damage from radiation therapy.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

The patient had paraneoplastic pemphigus without mucosal involvement.

Skin symptoms in lupus help diagnose and manage the disease early.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Zinc treatment improved skin and hair issues in a boy with a zinc-related condition.

The conclusion is that healthcare professionals should report adverse drug reactions to improve medication safety and patient care.

A 17-year-old in Saudi Arabia was diagnosed with a rare skin condition causing red-brown facial patches.

A rare hair follicle disorder can cause itchy, bluish-black bumps on the body.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

MTX and GC combinations are the most effective for early rheumatoid arthritis.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Adalimumab significantly improved Hidradenitis Suppurativa and quality of life in two patients.

Pemphigus patients with alopecia have more severe and treatment-resistant disease.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

A 15-year-old boy was correctly diagnosed with a rare skin condition after initially being misdiagnosed.

Digital gangrene can be an unusual first sign of late-onset lupus.

A rare scalp condition with hair loss was correctly diagnosed and treated, leading to hair regrowth.

COVID-19 can cause various skin symptoms that usually improve with proper treatment.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Some multiple sclerosis treatments may trigger hair loss conditions like alopecia areata.

A new cream, DHMEQ, reduces allergic skin inflammation effectively.